In the United States, nearly three million adults 18 years and older reported having active epilepsy during 2021 and 2022.
Analysis was by intention to treat. The outcomes reported were atrial or ventricular arrhythmia and a combined outcome of death or any arrhythmia. Carvedilol reduces the risk of atrial and ...